Ozempic Mass Tort Intake Template: GLP-1 Gastroparesis Qualification
The Ozempic Mass Tort Intake Template provides specialized clinical qualification for individuals who suffered severe gastroparesis, intestinal blockage, or deep venous thrombosis following the use of semaglutide medications like Ozempic and Wegovy under MDL 3094.
Screen prescription records, verify diagnostic testing documentation, and route review-ready master claimant files to pharmaceutical mass tort teams.
Four synchronous verification gates from lead to retainer.
Medication History Verification
Collects specific brand, dosage, dates of use, and prescribing physician details.
- Screen for Ozempic, Wegovy, Mounjaro
- Verify minimum 60-day use duration
- Prescription bottle photo OCR
Injury & Hospitalization Qualification
Validates primary qualifying medical diagnoses.
- Gastroparesis / severe stomach paralysis
- Bowel obstruction or ileus
- Emergency room or ICU hospital admission
Diagnostic Test Verification
Homeowner or patient uploads Gastric Emptying Study (GES) or endoscopy results.
- Extract GES retention percentages at 4 hours
- Flag pre-existing conditions (diabetic gastroparesis check)
- Extract facility names
HIPAA Release & Retainer Execution
Executes HIPAA medical authorization and legal representation agreement.
- Dual canvas signature on HIPAA release
- Client agreement countersign
- MDL plaintiff factsheet data prep
Docket-specific intake considerations.
What is the primary injury required for Ozempic mass tort claims?
Qualified claims typically require a formal medical diagnosis of gastroparesis (stomach paralysis), severe intestinal obstruction, or prolonged hospitalization following the use of Ozempic or Wegovy, supported by diagnostic testing.
Ready to deploy this workflow for your firm?
Experience automated legal intake in action.
Run your high-volume litigation and consumer dockets on an owned, high-speed intake pipeline.